自体造血干细胞移植恢复系统性硬化症患者调节性B细胞的抑制功能
该研究纳入22例系统性硬化症患者,在自体造血干细胞移植前及移植后30、60、120、180、360天采集外周血,用流式细胞术评估B细胞亚群的数量与功能。结果显示移植后初始B细胞频率升高、记忆B细胞频率下降,IL-10阳性调节性B细胞频率在180天升高,CD19+CD24hiCD38hi调节性B细胞在360天恢复抑制CD4+ T细胞产生Th1细胞因子的能力,提示AHSCT后免疫调节与抗纤维化机制改善。
要点
- AHSCT后初始B细胞频率升高、记忆B细胞频率下降,浆细胞频率在60天短暂下降。
- IL-10阳性调节性B细胞频率在移植后180天升高。
- CD19+CD24hiCD38hi调节性B细胞在360天恢复抑制Th1细胞因子的能力。
核心结论
- AHSCT后系统性硬化症患者B细胞亚群重建并向免疫调节表型偏移,调节性B细胞抑制功能恢复,可能有助于重建自身耐受和临床缓解。
研究设计与样本
- 研究纳入22例系统性硬化症患者,在移植前及AHSCT后30、60、120、180、360天采集外周血。
- 采用流式细胞术评估B细胞亚群免疫表型、B细胞细胞因子产生、信号通路及调节性B细胞的抑制能力。
主要发现
- 与移植前相比,初始B细胞频率在AHSCT后60至360天升高,记忆B细胞频率在同一时期下降。
- 浆细胞频率在AHSCT后60天短暂下降。
- IL-10阳性调节性B细胞CD19+CD24hiCD38hi与CD19+CD24hiCD27+频率在180天升高。
- AHSCT后重建的B细胞中细胞外信号调节激酶1/2和p38丝裂原活化蛋白激酶的磷酸化增加。
- CD19+CD24hiCD38hi调节性B细胞在AHSCT后360天恢复抑制CD4+ T细胞产生Th1细胞因子的能力,IL-6和TGF-β1阳性B细胞减少。
临床怎么用
- 结果提示AHSCT可能通过恢复调节性B细胞功能重建免疫耐受,为系统性硬化症移植后免疫重建监测提供B细胞亚群与功能指标参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The rationale of autologous haematopoietic stem cell transplantation (AHSCT) for autoimmune diseases is that high-dose immunosuppression eradicates autoreactive T and B cells and the infused autologous haematopoietic stem cells promote reconstitution of a naïve and self-tolerant immune system. The aim of this study was to evaluate the reconstitution of different B cell subsets, both quantitatively and functionally, in SSc patients treated with AHSCT. METHODS: Peripheral blood was harvested from 22 SSc patients before transplantation and at 30, 60, 120, 180 and 360 days post-AHSCT. Immunophenotyping of B cell subsets, B cell cytokine production, signalling pathways and suppressive capacity of regulatory B cells (Bregs) were assessed by flow cytometry. RESULTS: Naïve B cell frequencies increased from 60 to 360 days post-AHSCT compared with pre-transplantation. Conversely, memory B cell frequencies decreased during the same period. Plasma cell frequencies transiently decreased at 60 days post-AHSCT. IL-10-producing Bregs CD19+CD24hiCD38hi and CD19+CD24hiCD27+ frequencies increased at 180 days. Moreover, the phosphorylation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase increased in B cells reconstituted post-AHSCT. Notably, CD19+CD24hiCD38hi Bregs recovered their ability to suppress production of Th1 cytokines by CD4+ T cells at 360 days post-AHSCT. Finally, IL-6 and TGF-β1-producing B cells decreased following AHSCT. CONCLUSION: Taken together, these results suggest improvements in immunoregulatory and anti-fibrotic mechanisms after AHSCT for SSc, which may contribute to re-establishment of self-tolerance and clinical remission.
引用
- Lima-Júnior JR, Arruda LCM, Gonçalves MS, et al. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology (Oxford). 2021. PMID: 33724344. doi:10.1093/rheumatology/keab257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。